CD38 and Miyoshi myopathy: In an in vivo animal study, it has been demonstrated that changing CD38 expression through the shRNA-mediated knockdown of CD38 modifies mitochondrial transfer; moreover, blocking CD38 inhibited mitochondrial transport, caused a reduction in the amount of MM, and enhanced animal survival.